There were a host of medtech insights to be gained on the exhibitor floor of DeviceTalks Minnesota in September, from LVAD innovations at Abbott to cybersecurity tips from Green Hills Software to Xometry’s use of AI to help device makers secure better 3D printing and other manufacturing processes. Check out what editor Chris Newmarker discovered […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Medtronic launches trial for extravascular ICD
Medtronic (NYSE:MDT) said today that it launched a worldwide pivotal study to evaluate its extravascular implantable cardioverter defibrillator device for treating dangerously fast heart rhythms. The EV ICD system uses a device that is the same size as traditional, transvenous ICDs, but with a lead wire placed outside the heart and veins, designed to deliver defibrillation […]
Report: Docs could reduce adverse events with Boston Sci’s Watchman
This article has been updated to include comments from Boston Scientific. A recent review of FDA files has found nearly 3,000 adverse events related to Boston Scientific’s (NYSE:BSX) Watchman device. The Watchman left atrial appendage closure device, approved by the agency in March 2015, is designed to prevent blood clots that form in the heart’s […]
Gore wins CE Mark for Cardioform ASD septal occluder
W.L. Gore said yesterday that it won CE Mark approval in the European Union for its Cardioform ASD septal occluder for the percutaneous, transcatheter closure of ostium secundum atrial defects. The device won pre-market approval from the FDA for Cardioform ASD in June. The device is designed to close atrial septum defects of 8mm to 35mm […]
4C Medical pulls in $8m
4C Medical Technologies secured more than $8 million in an equity offering it hopes will reach the $20 million mark. The Maple Grove, Minn.-based company raised nearly $8.2 million in the offering, with $11.8 million remaining to be sold, according to an SEC Form D filed today. Forty-five unnamed investors have contributed to the offering. […]
Maquet recalls arterial filters
Getinge subsidiary Maquet Cardiovascular is recalling its Quart arterial filter, used during coronary bypass surgery, because transportation may compromise its sterile packaging. A transportation simulation test revealed the problem, according to an August 27, 2019, letter to customers. Patients who are exposed to non-sterile medical devices while undergoing extracorporeal circulation may develop an infection and […]
ControlRad drums up $15m Series B round
ControlRad said today that it completed a $15 million Series B round for the commercial launch of its Trace system for reducing radiation in fluoroscopically guided procedures. Norcross, Ga.-based ControlRad’s Trace system is the first FDA-cleared technology that can be integrated into existing mobile C-arms to reduce the ionizing radiation that can occur in FGP. […]
Endotronix expands Series D to $70m
Endotronix said today that it added $35 million to the Series D round it first closed a year ago for the Cordella cardiovascular monitoring technology it’s developing. The Lisle, Ill.-based company initially closed the Series D at $45 million on Sept. 14, 2018, earmarking the proceeds for CE Mark approval in the European Union and […]
TCT 2019: Boston Scientific slides on Acurate Neo TMVR trial miss
The Acurate Neo replacement heart valve being developed by Boston Scientific (NYSE:BSX) failed to show non-inferiority in a head-to-head comparison with the Sapien 3 valve made by Edwards Lifesciences (NYSE:EW), according to study data released at the annual Transcatheter Cardiovascular Technologies conference in San Francisco. The 739-patient Scope I study randomized increased-risk patients to either Acurate Neo […]
TCT 2019: Medtronic’s Resolute Onyx non-inferior to Biosensors Biofreedom stent
A study comparing the Resolute Onyx drug-eluting stent from Medtronic (NYSE:MDT) and the BioFreedom stent made by Biosensors International (PINK:BSNRY) showed the Medtronic device to be non-inferior in patients on a one-month dual anti-platelet therapy regimen, according to results presented yesterday at the annual Transcatheter Cardiovascular Technologies conference in San Francisco. Medtronic launched the 2,000-patient study […]
FDA approves early feasibility study for new Medtronic TMVR
Medtronic (NYSE:MDT) said today that it has received FDA approval to begin an early feasibility study for its Intrepid transcatheter mitral valve replacement (TMVR) system using a minimally-invasive transfemoral access approach. The announcement builds upon primary endpoint outcomes of the Intrepid TMVR Apollo clinical trial using the transapical approach, published in the Journal of the […]